1 |
Alcon Research, Ltd. v. Watson Laboratories, Inc. |
1:17-cv-00252 |
D.Del. |
|
|
|
|
2 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
3 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
4 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
5 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
6 |
Alcon Research, Ltd. v. Watson Laboratories, Inc. |
1:16-cv-00238 |
D.Del. |
|
|
|
|
7 |
Alcon Research, Ltd. v. Watson Laboratories, Inc. |
1:16-cv-00129 |
D.Del. |
|
|
|
|
8 |
Alcon Research, Ltd. v. Watson Laboratories, Inc., et al., |
1:15-cv-01159 |
D.Del. |
|
|
|
|
9 |
UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. |
3:15-cv-05723 |
D.N.J. |
|
|
|
|
10 |
FERRING B.V. et al v. ACTAVIS, INC. et al |
2:15-cv-04222 |
D.N.J. |
|
|
|
|
11 |
FERRING B.V. et al v. ACTAVIS, INC. et al |
2:15-cv-04222 |
D.N.J. |
|
|
|
|
12 |
FERRING B.V. et al v. ACTAVIS, INC. et al |
2:15-cv-04222 |
D.N.J. |
|
|
|
|
13 |
GILEAD SCIENCES, INC. et al v. SIGMAPHARM LABORATORIES, LLC. |
1:15-cv-02350 |
D.N.J. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
14 |
GILEAD SCIENCES, INC. et al v. SIGMAPHARM LABORATORIES, LLC. |
1:15-cv-02350 |
D.N.J. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
15 |
MCNEIL-PPC, INC. et al v. WATSON LABORATORIES, INC. |
1:15-cv-02197 |
D.N.J. |
|
|
|
|
16 |
MCNEIL-PPC, INC. et al v. WATSON LABORATORIES, INC. |
1:15-cv-02197 |
D.N.J. |
|
|
|
|
17 |
Purdue Pharma L.P. v. Watson Laboratories Inc. |
1:14-cv-01410 |
D.Del. |
|
|
|
|
18 |
ASTRAZENECA AB v. WATSON LABORATORIES, INC. et al |
3:14-cv-03428 |
D.N.J. |
|
|
|
|
19 |
AMARIN PHARMA, INC. et al v. WATSON LABORATORIES, INC. et al |
3:14-cv-03259 |
D.N.J. |
|
|
|
|
20 |
AMARIN PHARMA, INC. et al v. WATSON LABORATORIES, INC. et al |
3:14-cv-03259 |
D.N.J. |
|
|
|
|
21 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:14-cv-03126 |
D.N.J. |
|
|
|
|
22 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
23 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
24 |
Sanofi et al v. Watson Laboratories Inc. |
1:14-cv-00265 |
D.Del. |
|
|
|
|
25 |
Sanofi et al v. Watson Laboratories Inc. |
1:14-cv-00265 |
D.Del. |
|
|
|
|
26 |
Sanofi et al v. Watson Laboratories Inc. et al |
1:14-cv-00264 |
D.Del. |
|
|
|
|
27 |
Sanofi et al v. Watson Laboratories Inc. et al |
1:14-cv-00264 |
D.Del. |
|
|
|
|
28 |
DEPOMED, INC. v. BANNER PHARMACAPS INC. et al |
1:13-cv-00653 |
M.D.N.C. |
|
|
|
|
29 |
DEPOMED, INC. v. BANNER PHARMACAPS INC. et al |
2:13-cv-04542 |
D.N.J. |
|
|
|
|
30 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:13-cv-01272 |
D.Del. |
|
|
|
|
31 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:13-cv-01272 |
D.Del. |
|
|
|
|
32 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:13-cv-01272 |
D.Del. |
|
|
|
|
33 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
34 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
35 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
36 |
Purdue Pharma L.P. et al v. Watson Laboratories, Inc. et al |
1:13-cv-00762 |
S.D.N.Y. |
|
|
|
|
37 |
Purdue Pharma L.P. et al v. Watson Laboratories, Inc. et al |
1:13-cv-00762 |
S.D.N.Y. |
|
|
|
|
38 |
Avanir Pharmaceuticals Inc. v. Watson Pharmaceuticals Inc. et al |
1:12-cv-01124 |
D.Del. |
|
|
|
|
39 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
40 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
41 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
42 |
Sunovion Pharmaceuticals Inc. v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00993 |
D.Del. |
|
|
|
|
43 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:12-cv-04571 |
D.N.J. |
|
|
|
|
44 |
Allergan, Inc. v. Sandoz, Inc. et al |
2:12-cv-00207 |
E.D.Tex. |
|
|
|
|
45 |
Allergan, Inc. v. Sandoz, Inc. et al |
2:12-cv-00207 |
E.D.Tex. |
|
|
|
|
46 |
Allergan, Inc. v. Sandoz, Inc. et al |
2:12-cv-00207 |
E.D.Tex. |
|
|
|
|
47 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
48 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
49 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
50 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:12-cv-00161 |
D.Del. |
|
|
|
|